Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Multimodal Telerehabilitation in Patients Undergoing CAR-T Cell Immunotherapy — Stella

View on ClinicalTrials.gov

Recruiting

Back to Lymphoma trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

United States

Huntsman Cancer Institute at University of Utah, Salt Lake City, Utah

Key details

Sponsor

University of Utah

Collaborators

United States Department of Defense

Enrollment target

~40 participants

Started

September 2025

Primary completion

January 2029

Age range

21 Years and older

Last updated February 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.